China Underground > China News > China’s Sinopharm announced its coronavirus vaccine is 79.34% effective

China’s Sinopharm announced its coronavirus vaccine is 79.34% effective

China plans to vaccinate 50 million people before the Chinese New Year.

The vaccine produced by the Chinese pharmaceutical giant Sinopharm is 79.43% effective.

Interim analysis of phase 3 clinical trials shows that the vaccine is safe and that people who received two doses produced high levels of antibodies, according to Beijing Biological Products Institute Co., a subsidiary of Sinopharm.

Sinopharm said they are awaiting formal approval from Chinese regulators to distribute the vaccine to the public.

The vaccine has already been administered to hundreds of thousands of people under an emergency program approved by the Chinese government.

By November, nearly 1 million people had received the vaccine.

According to the few details provided, the vaccine follows the guidelines and safety standards of the World Health Organization and the Chinese regulator.

The Chinese vaccine is less effective than those produced by Pfizer-BioNTech and Moderna, which have an efficacy rate of about 95%, while the Russian Sputnik V vaccine has an efficacy of 91%. The vaccine produced by Oxford University and AstraZeneca is 70% effective.

Its efficacy is, therefore, lower than what was announced by the United Arab Emirates last December 9. The results from the UAE dated back to July.

China is poised to send hundreds of millions of doses to the 16 countries that conducted the last phase of trials since the coronavirus is scarcely present within the country’s borders.

Compared to Pfizer’s and Moderna’s vaccines, Sinopharm’s vaccine does not require special freezing temperatures for storage, making transport and distribution easier, especially in developing countries.

Subscribe to China Underground and get the free magazine 'Planet China'

* indicates required

View previous campaigns.

By clicking Sign Up, you agree to our terms and conditions.

You can unsubscribe at any time by clicking the link in the footer of our emails.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Previous

Core module of China’s space station to be launched in the first half of 2021

Hong Kongers who tried to flee to Taiwan sentenced in China to up to 3 years

Next

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.